ArticleBrain sciences2026
An Augmented Reality-Based Navigation System for Stereotactic Brain Biopsy with Multi-Objective Path Planning and Hybrid Registration.
Article in Brain sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStereotactic brain biopsy is the gold standard for the pathological diagnosis of malignant brain tumors. However, conventional procedures rely heavily on manual path planning and unintuitive navigation, which significantly increase the risk of severe complications and impose an additional cognitive burden on surgeons.
methodsWe propose an augmented reality-based navigation system that synergizes multi-objective path planning with hybrid registration. Preoperatively, the system utilizes a constrained multi-objective optimization (MOO) model derived from clinical criteria to automatically calculate and visualize optimal biopsy paths within a three-dimensional anatomical environment. Intraoperatively, the system performs rapid initial alignment using quick response (QR) codes, followed by precise refinement through anatomical landmarks. This process ultimately enables the highly accurate, real-time overlay of the surgical path and anatomical models onto the patient's operative field.
resultsAn expert study across four common brain tumor locations demonstrated that the MOO model significantly outperformed manual methods in satisfying safety criteria. The hybrid registration reduced the mean fiducial registration error (FRE) from 4.19 ± 1.11 mm to 2.37 ± 0.91 mm (
conclusionsThis system assists stereotactic brain biopsy through automated path planning and immersive augmented reality-based guidance, highlighting its potential to support surgical workflow consistency and procedural safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.